0.00
100.00%
-0.833
アフターアワーズ:
.83
0.83
+
Invo Bioscience Inc (INVO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
14.08%
1.5763
|
1.3818 | 0.9749 | 0.3159 | 0.348 |
Cost Of Revenue |
0.8502
|
- | - | - | 0.0726 |
Gross Profit |
0.7261
|
- | - | - | 0.2755 |
Operating Expenses
|
42.14%
1.6724
|
2.8902 | 1.8612 | 2.3819 | 2.5819 |
Interest Income/Expense |
0.41%
0.1813
|
0.182 | 0.3521 | 0.1752 | 0.2166 |
Benefits Costs and Expenses |
5.44%
3.171
|
3.3535 | 2.2214 | 2.5535 | 2.8989 |
Costs And Expenses |
24.78%
2.5227
|
3.3535 | 2.2214 | 2.5535 | 2.8989 |
Depreciation and Amortization |
60.28%
0.227
|
0.1416 | 0.0205 | 0.0197 | 0.0191 |
Operating Income/Loss |
37.26%
-0.9464
|
-1.5085 | -0.8863 | -2.066 | -2.3064 |
Nonoperating Income/Loss |
39.94%
-0.6483
|
-0.4633 | -0.3603 | -0.1717 | -0.2445 |
Income/Loss Before Equity Method Investments |
17.95%
-1.5948
|
-1.9436 | -1.2384 | -2.2414 | -2.5231 |
Income/Loss From Equity Method Investments |
100.37%
0.000104
|
-0.0282 | -0.00816 | 0.00379 | -0.0277 |
Income/Loss From Continuing Operations Before Tax |
19.12%
-1.5947
|
-1.9717 | -1.2466 | -2.2376 | -2.5509 |
Income/Loss From Continuing Operations After Tax |
20.25%
-1.5947
|
-1.9995 | -1.2466 | -2.2405 | -2.5509 |
Net Income/Loss
|
19.97%
-1.5965
|
-1.9948 | -1.2484 | -2.2405 | -2.5509 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
634.19%
3.8019
|
0.5178 | 1.7769 | 0.7323 | 12.45 |
Diluted Average Shares |
634.19%
3.8019
|
0.5178 | 1.7769 | 0.7323 | 12.45 |
Basic Earnings Per Share |
166.67%
-0.42
|
0.63 | -0.70 | -3.06 | -0.20 |
Diluted Earnings Per Share |
166.67%
-0.42
|
0.63 | -0.70 | -3.06 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):